Catalent Experts to Discuss Evolving Strategies for Global Clinical Supply at Upcoming Conferences
Catalent, a global leader in clinical supply services, today announced that three of its experts will be speaking on current market trends and strategies within the industry at two upcoming conferences, Outsourcing in Clinical Trials East Asia, and Outsourcing in Clinical Trials Southern California 2021.
SOMERSET, N.J., Nov. 18, 2021 /PRNewswire-PRWeb/ -- Catalent, a global leader in clinical supply services, today announced that three of its experts will be speaking on current market trends and strategies within the industry at two upcoming conferences, Outsourcing in Clinical Trials East Asia, and Outsourcing in Clinical Trials Southern California 2021.
First, at Outsourcing in Clinical Trials East Asia, Nicole Gray, Director of Strategic Supply Solutions, will present at 10:30 a.m. Korea Standard Time (KST) on Tuesday, Nov. 30. Her talk, entitled "Exploring Direct-to-Patient Clinical Supply Strategies for Multi-Country Decentralized Trials" will discuss several of the direct-to-patient models currently available, their benefits and possible limitations, and the option to combine one or more model into a hybrid approach that better meets the needs of trial sponsors and patients.
Additionally, on Wednesday, Dec. 1 at 11 a.m. KST, Julie Delaney, Director of Project Management, APAC, will participate in a panel discussion entitled "Clinical Trials in Asia (Korea, China, Japan, Taiwan, India)" to discuss efficient strategies to manage multiple countries' regulations for global trials, and achieve increased productivity and high-quality results from all operation sites.
At Outsourcing in Clinical Trials Southern California 2021, which is being held at the Marriott San Diego La Jolla hotel on Dec. 7-8, Michael McNear, Director of Operations at Catalent's new clinical supply facility in San Diego, will be presenting. His talk at 4:30 p.m. PST on Tuesday, Dec. 7, entitled "Strategies to Avoid Costly Errors When Supplying Early Phase Studies", will discuss how to evaluate a prospective clinical supply partner, the benefits of integrated supply services, and understanding the role of a clinical supply manager in the strategic planning process.
With a network spanning the U.S., U.K., Germany, Singapore, Japan, and China, plus more than 50 additional global depots, Catalent's clinical supply services can handle a broad range of international compliance and distribution requirements to support global clinical trials.
To find out more information about these events, visit https://www.clinical.catalent.com/news-and-events/#events
About Catalent Clinical Supply Services
Catalent is a global leader in clinical supply services, with comprehensive and flexible solutions for small molecules, biologics, and cell and gene therapies and integrated solutions to accelerate speed to clinic. Catalent offers a full range of services including clinical supply management, comprehensive packaging solutions, comparator sourcing, cold chain storage and global distribution and specialized supply chain services including direct-to-patient and demand-led supply. With nine CGMP clinical packaging facilities and over 50 strategically located depots on six continents combined with more than 25 years' experience across thousands of studies in more than 80 countries, Catalent has the comprehensive services, global scale and expertise necessary to reliably supply clinical trials of all sizes and complexity anywhere in the world.
About Catalent
Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world.
With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs. Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply over 70 billion doses of more than 7,000 products to over 1,000 customers annually.
Catalent's expert workforce exceeds 17,000, including more than 2,500 scientists and technicians. Headquartered in Somerset, New Jersey, the company generated $4 billion in revenue in its 2021 fiscal year. For more information, visit http://www.catalent.com.
More products. Better treatments. Reliably supplied.™
Media Contact
Chris Halling, Catalent, +447580041073, [email protected]
Richard Kerns, Northern Exposure Public Relations, +441617285880, [email protected]
SOURCE Catalent
Share this article